On Friday, Incyte Corp (NASDAQ: INCY) opened higher 2.65% from the last session, before settling in for the closing price of $67.06. Price fluctuations for INCY have ranged from $50.35 to $83.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 14.55% over the last five years. Company’s average yearly earnings per share was noted -64.22% at the time writing. With a float of $189.56 million, this company’s outstanding shares have now reached $192.80 million.
The firm has a total of 2524 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.4%, operating margin of -1.28%, and the pretax margin is 6.72%.
Incyte Corp (INCY) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Incyte Corp is 1.60%, while institutional ownership is 96.19%. The most recent insider transaction that took place on Dec 13 ’24, was worth 45,916. In this transaction Principal Accounting Officer of this company sold 650 shares at a rate of $70.64, taking the stock ownership to the 23,962 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Principal Accounting Officer sold 650 for $69.31, making the entire transaction worth $45,052. This insider now owns 23,312 shares in total.
Incyte Corp (INCY) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.14% during the next five years compared to 38.99% growth over the previous five years of trading.
Incyte Corp (NASDAQ: INCY) Trading Performance Indicators
Check out the current performance indicators for Incyte Corp (INCY). In the past quarter, the stock posted a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.34. Likewise, its price to free cash flow for the trailing twelve months is 443.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.14, a number that is poised to hit 1.51 in the next quarter and is forecasted to reach 5.92 in one year’s time.
Technical Analysis of Incyte Corp (INCY)
Analysing the last 5-days average volume posted by the [Incyte Corp, INCY], we can find that recorded value of 3.11 million was better than the volume posted last year of 2.35 million. As of the previous 9 days, the stock’s Stochastic %D was 17.92%. Additionally, its Average True Range was 2.26.
During the past 100 days, Incyte Corp’s (INCY) raw stochastic average was set at 36.39%, which indicates a significant increase from 24.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.77% in the past 14 days, which was higher than the 36.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.23, while its 200-day Moving Average is $63.33. Now, the first resistance to watch is $69.67. This is followed by the second major resistance level at $70.50. The third major resistance level sits at $71.89. If the price goes on to break the first support level at $67.45, it is likely to go to the next support level at $66.06. Now, if the price goes above the second support level, the third support stands at $65.23.
Incyte Corp (NASDAQ: INCY) Key Stats
There are currently 192,650K shares outstanding in the company with a market cap of 13.61 billion. Presently, the company’s annual sales total 3,696 M according to its annual income of 597,600 K. Last quarter, the company’s sales amounted to 1,138 M and its income totaled 106,460 K.
